Playback speed
10 seconds
Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutuzumab vs. Chlorambucil & Obinutuzumab for Treatment-Naïve CLL
795 views
April 3, 2023
Login to view comments.
Click here to Login